Related Experiment Videos
Antiandrogenic steroidal sulfonylpyrazoles
R G Christiansen1, M R Bell, T E D'Ambra
1Department of Chemistry, Sterling Research Group, Rensselaer, New York 12144.
Journal of Medicinal Chemistry
|August 1, 1990
Summary
A novel steroidal sulfonylpyrazole compound selectively blocks androgen receptor activity without promoting androgenic effects. This discovery offers a promising avenue for developing targeted anti-androgenic therapies.
Area of Science:
- Medicinal Chemistry
- Endocrinology
- Pharmacology
Background:
- Steroidal pyrazoles exhibit both androgenic and antiandrogenic properties.
- Selective androgen receptor modulators are crucial for therapeutic interventions.
Purpose of the Study:
- To synthesize and evaluate a novel steroidal sulfonylpyrazole (compound 1) for selective antiandrogenic activity.
- To investigate the structure-activity relationship for optimizing antiandrogenic potency and minimizing androgenic effects.
Main Methods:
- In vitro binding assays with rat ventral prostate androgen receptor.
- In vivo studies using testosterone propionate-induced ventral prostate weight increase in castrated immature male rats.
- Evaluation of androgenic and antiandrogenic activities of synthesized compounds.
Main Results:
- Compound 1 demonstrated potent inhibition of androgen receptor activity in vitro and antiandrogenic effects in vivo (ED50 = 15 mg/kg).
- Unlike its parent compound, compound 1 lacked significant androgenic activity.
- N-1'-alkysulfonyl substitution was key to isolating antiandrogenic properties.
Conclusions:
- Introduction of an N-1'-methylsulfonyl group effectively separates antiandrogenic from androgenic activity in steroidal heterocycles.
- Optimal antiandrogenic efficacy and selectivity were achieved with an N-1'-methylsulfonyl group and a C-17 alpha-substituent.